Forest plot of the improvement in primary endpoints. by Jin-Min Gu (17915039)

Subjects:

Radar graph of absolute correlations between age, disease duration and disease variables. by Sasivimol Virameteekul (11868977)

Subjects:

Three portions are defined by subdividing both the lesser and the greater curvatures into three equal lengths. by Masaaki Kodama (212905)

Statistically-significant cytokine changes between the pre-infusion and post-infusion blood draws plot of the mean (dot) and confidence interval (whiskers) for the coefficients of... by Jordan K. Abbott (8934239)

Subjects:

HEp-2 titers and outcomes. by Tejaswini Kulkarni (716851)

Subjects:

S1 Dataset - by Tejaswini Kulkarni (716851)

Subjects:

Triple-modality autoantibody reduction regimen. by Tejaswini Kulkarni (716851)

Subjects:

Patient demographic characteristics. by Tejaswini Kulkarni (716851)

Subjects:

Associations with anti-Hep-2 titers at initiation of therapy. by Tejaswini Kulkarni (716851)

Subjects:

HEp-2 indirect Immunofluorescence (IFA) of IPF Plasma. by Tejaswini Kulkarni (716851)

Subjects:

Overall survival and responses to autoantibody reduction therapy. by Tejaswini Kulkarni (716851)

Subjects:

LSV2 abundance is greater in weak colonies. by Cayley Faurot-Daniels (9354170)

Correlation of Module Membership (MM) with Gene Significance (GS) in the four most relevant modules for PD. by Guanghao Xin (17583227)

Between-group comparison of change in VAS score by disease duration. by Myung-Geun Song (2297794)

Subjects:

Synthesis and Preclinical Evaluation of Novel ^99mTc-Labeled FAPI-46 Derivatives with Significant Tumor Uptake and Improved Tumor-to-Nontarget Ratios by Qing Ruan (349572)

Subjects:

Radar graph of odds ratio visualization for disease milestones difference by age and disease duration. by Sasivimol Virameteekul (11868977)

Subjects:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

Drug screening test accuracy for significance level 0.10. by Elizabeth Rosenzweig (383589)

Subjects:

Drug screening test accuracy for significance level 0.01. by Elizabeth Rosenzweig (383589)

Subjects: